Skip to search boxSkip to navigationSkip to main content

Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Pregnancy-associated breast cancer is challenging to treat. Treatment with chemotherapeutic agents such as anthracyclines poses a risk of cardiotoxicity, despite being considered safe after the second trimester of pregnancy. Management requires multidisciplinary comanagement with cardio-obstetrics, cardiology-oncology, maternal-fetal medicine, and oncology.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

102141

Journal (Volume, Issue Number)

JACC: Case Reports (Volume 28)

Publication milestones

  • Published - 12/20/2023

Publication status

Published - 12/20/2023

Publication IDs

  • Scopus: 85180102865
  • ORCID: /0000-0003-0253-1174/work/172679176

Publication metrics

Metrics

Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
0.50
Fractional count
4
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
2
Captures
11